NO20073419L - Oral suspensjon omfattende meloxikam - Google Patents

Oral suspensjon omfattende meloxikam

Info

Publication number
NO20073419L
NO20073419L NO20073419A NO20073419A NO20073419L NO 20073419 L NO20073419 L NO 20073419L NO 20073419 A NO20073419 A NO 20073419A NO 20073419 A NO20073419 A NO 20073419A NO 20073419 L NO20073419 L NO 20073419L
Authority
NO
Norway
Prior art keywords
meloxicam
oral suspension
pain
acute
preparation
Prior art date
Application number
NO20073419A
Other languages
English (en)
Norwegian (no)
Inventor
Caspar Peter Elisabet Biesmans
Bart De Spiegeleer
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073419(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20073419L publication Critical patent/NO20073419L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
NO20073419A 2004-12-06 2007-07-03 Oral suspensjon omfattende meloxikam NO20073419L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106318 2004-12-06
PCT/EP2005/056419 WO2006061351A1 (en) 2004-12-06 2005-12-02 Oral suspension comprising meloxicam

Publications (1)

Publication Number Publication Date
NO20073419L true NO20073419L (no) 2007-07-03

Family

ID=34929998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073419A NO20073419L (no) 2004-12-06 2007-07-03 Oral suspensjon omfattende meloxikam

Country Status (14)

Country Link
US (1) US7705000B2 (de)
EP (1) EP1824493B1 (de)
JP (1) JP2008523024A (de)
AT (1) ATE404206T1 (de)
AU (1) AU2005313365A1 (de)
CA (1) CA2586288A1 (de)
DE (1) DE602005009016D1 (de)
DK (1) DK1824493T3 (de)
ES (1) ES2313452T3 (de)
NO (1) NO20073419L (de)
PL (1) PL1824493T3 (de)
PT (1) PT1824493E (de)
TW (1) TW200635598A (de)
WO (1) WO2006061351A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2034958B1 (de) * 2006-05-19 2009-10-28 Norbrook Laboratories Limited Stabile wässrige suspension mit gutem geschmack
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
US20150231156A1 (en) * 2007-11-13 2015-08-20 Meritage Pharma, Inc. Corticosteroid compositions
EP2328585A4 (de) * 2008-09-05 2011-09-21 Troy Lab Pty Ltd Behandlung neugeborener fohlen mit meloxicam
CA2777366C (en) * 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
GB201117858D0 (en) * 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
PL239019B1 (pl) * 2017-07-14 2021-10-25 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
RU2020108079A (ru) * 2017-08-24 2021-09-24 Цзянсу Хэнжуй Медицин Ко., Лтд. Инъекционная фармацевтическая композиция, содержащая мелоксикам, и способ ее получения
CN116327960A (zh) * 2018-05-11 2023-06-27 南京清普生物科技有限公司 一种美洛昔康组合物、制剂及其制备方法与应用
EA202190045A1 (ru) * 2018-06-15 2021-03-17 Янссен Фармацевтика Нв Составы/композиции, содержащие ибрутиниб
GB2585825B (en) * 2019-07-09 2023-03-22 Lexon Uk Holdings Ltd Suspending vehicle formulation
KR102530032B1 (ko) 2019-09-18 2023-05-09 정원구 반려동물용 현탁액 조성물 및 이의 제조방법
CN113143863A (zh) * 2020-01-22 2021-07-23 浙江贝灵生物医药有限公司 一种口服溶媒组合物及其制备方法与应用
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法
CN115634198A (zh) * 2021-07-20 2023-01-24 浙江贝灵生物医药有限公司 用于水难溶性物质的溶媒组合物及其制备方法与应用
CN116327711B (zh) * 2022-01-18 2026-01-23 中国人民解放军军事科学院军事医学研究院 一种生物利用度高的美洛昔康纳米晶组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
WO1999009988A1 (en) 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
EP0945131A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
JP4234907B2 (ja) 1998-05-15 2009-03-04 わかもと製薬株式会社 抗炎症点眼剤
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
WO2002098352A2 (en) * 2001-06-01 2002-12-12 Pozen Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
JP2004131495A (ja) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co Ltd 非ステロイド系抗炎症剤の局所送達用医薬組成物
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
AU2005313365A1 (en) 2006-06-15
EP1824493B1 (de) 2008-08-13
US20090221563A1 (en) 2009-09-03
WO2006061351A1 (en) 2006-06-15
JP2008523024A (ja) 2008-07-03
EP1824493A1 (de) 2007-08-29
TW200635598A (en) 2006-10-16
CA2586288A1 (en) 2006-06-15
DE602005009016D1 (de) 2008-09-25
DK1824493T3 (da) 2008-12-08
ATE404206T1 (de) 2008-08-15
US7705000B2 (en) 2010-04-27
PL1824493T3 (pl) 2009-01-30
ES2313452T3 (es) 2009-03-01
PT1824493E (pt) 2008-11-18

Similar Documents

Publication Publication Date Title
NO20073419L (no) Oral suspensjon omfattende meloxikam
IL249263A0 (en) Methods and systems for extracorporeal organ treatment
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
MX2007005870A (es) Composiciones que comprenden derivados de escilo-inositol y metodos para tratar trastornos de agregacion de proteinas.
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
MY135829A (en) Analeptic and drug combinations
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
EA200801890A1 (ru) Средство для лечения шума в ушах
EA200900575A1 (ru) Композиция, содержащая антагонист рецептора nk1 и ssri, для лечения шума в ушах и потери слуха
ATE460415T1 (de) Therapeutische pyrazoloä3,4-büpyridine und - indazole
PL1865966T3 (pl) Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli
WO2010129788A3 (en) Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
WO2005113814A3 (en) Biomarkers of chronic pelvic pain syndrome
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
NO20065473L (no) IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.
JO2666B1 (en) Use of Agomelatine in obtaining medicaments intented for the treatment of Bipolar disorders
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
ITFI20060002U1 (it) "onivades" sedia che si trasforma in tavolino e viceversa.
Mizutani The Characteristics of and the Soarce Realized “Kosen”(College of Technology) Education
TH0701005261A (th) แอนติ-Notch3 อะโกนิสต์ แอนติบอดีตัวใหม่และการใช้งานในการป้องกันและการบำบัดโรคที่เกี่ยวข้องกับ Notch3
SE0300323D0 (sv) Naturmedel med smärtlindrande egenskap

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application